Nectar Lifesciences Limited

NSE:NECLIFE India Drug Manufacturers - Specialty & Generic
Market Cap
$28.36 Million
₹2.46 Billion INR
Market Cap Rank
#26989 Global
#1439 in India
Share Price
₹10.95
Change (1 day)
-1.26%
52-Week Range
₹10.95 - ₹27.17
All Time High
₹59.47
Categories
Companies in India Drug Manufacturers - Specialty & Generic
About

Nectar Lifesciences Limited manufactures, distributes, markets and sells pharmaceutical products in India and internationally. The company offers cephalosporins, includes pharmaceutical ingredients and intermediates comprising cefixime, cefuroxime axetil amorphous, cefuroxime axetil crystalline, cefotaxime sodium, ceftriaxone sodium, cefixime trihydrate, cefuroxime axetil, cefpodoxime proxetil an… Read more

Nectar Lifesciences Limited - Asset Resilience Ratio

Latest as of September 2025: 0.36%

Nectar Lifesciences Limited (NECLIFE) has an Asset Resilience Ratio of 0.36% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
₹64.60 Million
Cash + Short-term Investments
Total Assets
₹18.15 Billion
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (2006–2025)

This chart shows how Nectar Lifesciences Limited's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Nectar Lifesciences Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₹59.30 Million 0.33%
Short-term Investments ₹5.29 Million 0.03%
Total Liquid Assets ₹64.60 Million 0.36%

Asset Resilience Insights

  • Limited Liquidity: Nectar Lifesciences Limited maintains only 0.36% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Nectar Lifesciences Limited Industry Peers by Asset Resilience Ratio

Compare Nectar Lifesciences Limited's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF 		Drug Manufacturers - Specialty & Generic -0.02%
Kamada
NASDAQ:KMDA 		Drug Manufacturers - Specialty & Generic 21.63%
Dongwha Pharm.Co.Ltd
KO:000020 		Drug Manufacturers - Specialty & Generic 1.92%
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 		Drug Manufacturers - Specialty & Generic 0.46%
Yuhan Corp.
KO:000100 		Drug Manufacturers - Specialty & Generic 0.99%
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 		Drug Manufacturers - Specialty & Generic 1.81%
Kotra Industries Bhd
KLSE:0002 		Drug Manufacturers - Specialty & Generic 9.82%
Yuyu Pharma Inc
KO:000227 		Drug Manufacturers - Specialty & Generic 1.74%

Annual Asset Resilience Ratio for Nectar Lifesciences Limited (2006–2025)

The table below shows the annual Asset Resilience Ratio data for Nectar Lifesciences Limited.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-03-31 0.03% ₹5.30 Million ₹20.47 Billion +0.00pp
2024-03-31 0.02% ₹4.95 Million ₹21.91 Billion +0.01pp
2023-03-31 0.01% ₹3.15 Million ₹21.89 Billion 0.00pp
2022-03-31 0.02% ₹4.61 Million ₹23.91 Billion +0.00pp
2021-03-31 0.02% ₹4.57 Million ₹24.71 Billion +0.01pp
2020-03-31 0.01% ₹1.66 Million ₹26.33 Billion -0.01pp
2019-03-31 0.02% ₹5.06 Million ₹27.05 Billion +0.00pp
2018-03-31 0.02% ₹5.09 Million ₹27.24 Billion +0.00pp
2017-03-31 0.02% ₹4.08 Million ₹25.81 Billion 0.00pp
2016-03-31 0.02% ₹5.23 Million ₹25.56 Billion +0.00pp
2015-03-31 0.02% ₹4.36 Million ₹25.10 Billion +0.00pp
2014-03-31 0.01% ₹3.14 Million ₹23.94 Billion 0.00pp
2013-03-31 0.01% ₹3.19 Million ₹22.74 Billion +0.01pp
2012-03-31 0.01% ₹1.41 Million ₹21.21 Billion -5.92pp
2011-03-31 5.92% ₹1.07 Billion ₹18.13 Billion -0.60pp
2010-03-31 6.52% ₹965.53 Million ₹14.80 Billion -1.32pp
2009-03-31 7.84% ₹1.01 Billion ₹12.86 Billion -6.90pp
2008-03-31 14.74% ₹1.40 Billion ₹9.49 Billion -0.86pp
2007-03-31 15.60% ₹1.21 Billion ₹7.77 Billion +0.82pp
2006-03-31 14.77% ₹675.67 Million ₹4.57 Billion --
pp = percentage points